Alberta Health Contracts Under Scrutiny: A Deep Dive into Procurement Failures
A recently released addendum to a report investigating Alberta Health Services (AHS) contracts has revealed further complications surrounding a $56-million deal for children’s pain medication. Retired Manitoba justice Raymond Wyant’s investigation found that forensic accountants were unable to justify the contract’s value, raising serious questions about procurement practices within AHS.
The $7 Million Discrepancy and Unaccounted Funds
The addendum report details how AHS renegotiated a five-year contract with MHCare in July 2023, increasing the value by $7 million. This occurred after the province failed to secure Health Canada approval for the initial agreement to import five million bottles of medication from Turkish supplier Atabay Pharmaceuticals. The renegotiated contract aimed to procure alternative, approved Atabay products. Yet, RSM, the forensic accounting firm engaged by Wyant, could not substantiate the $56-million price tag.
Adding to the concerns, RSM reported that AHS had paid $42 million to MHCare for products that, as of October 31, 2025, had not been delivered. This substantial sum remains unaccounted for, fueling public and political scrutiny.
Conflict of Interest and Wasteful Spending
The investigation initially uncovered a conflict of interest involving Jitendra Prasad, an AHS employee who recommended purchasing intravenous acetaminophen solution when the original medication import faced hurdles. Prasad had a relationship and email address associated with MHCare while working to source the medication. The latest report highlights the extent of the waste: nearly 807,000 bottles – 55% of the medication received – were disposed of at a hazardous waste plant, while 44% were donated overseas. Only about 1% reached hospitals and pharmacies.
Broader Investigations and Political Fallout
The AHS contracting practices are currently the subject of multiple investigations. A wrongful dismissal lawsuit filed by former AHS CEO Athana Mentzelopoulos alleges she was terminated for questioning these incredibly contracts, specifically those related to children’s medication and private surgical facilities. The government and AHS deny these allegations, claiming her dismissal was due to performance issues.
The RCMP are also investigating, having recently searched MHCare’s offices. These investigations stem from allegations that AHS awarded lucrative contracts to companies controlled by MHCare CEO Sam Mraiche, including during the COVID-19 pandemic for personal protective equipment.
Government Response and Recommendations
The Alberta government maintains that the Wyant report exonerates elected officials and political staff from wrongdoing, attributing the issues to failures within AHS’s contract management. Assistant Deputy Minister Yonathan Sumamo stated the government has accepted all 18 of Wyant’s recommendations, focusing on strengthening oversight, accountability, and transparency in procurement.
These recommendations include a centralized system for conflict of interest declarations, a vendor code of conduct, whistleblower protection for AHS employees, and mandatory training on conflict of interest disclosures. Contracts exceeding $10 million will now require review by a procurement lawyer.
What’s Next for Alberta’s Healthcare Procurement?
The fallout from the Wyant report is likely to continue. Opposition parties, like the NDP, are calling for a public inquiry to fully investigate the government’s connections to the contracting issues. The focus will be on ensuring public funds are used effectively and transparently, and that conflicts of interest are proactively addressed.
Did you know?
The initial order for children’s pain medication from Turkey was approximately ten times larger than what Alberta officials initially believed was needed.
FAQ
Q: What were the key findings of the Wyant report?
A: The report found significant failures in AHS’s procurement processes, including a lack of adherence to its own policies, conflicts of interest, and questionable contract values.
Q: Was anyone found to be directly responsible for wrongdoing?
A: The report did not find evidence of wrongdoing by elected officials or political staff, but identified failures within AHS’s decision-making processes.
Q: What is the government doing to address the issues?
A: The government has accepted all 18 of Wyant’s recommendations and is implementing changes to improve oversight, accountability, and transparency in procurement.
Q: What is the status of the RCMP investigation?
A: The RCMP investigation is ongoing, with recent searches conducted at MHCare’s offices.
Pro Tip: Regularly reviewing and updating procurement policies is crucial for preventing similar issues in the future. Transparency and independent oversight are key to maintaining public trust.
Stay informed about the ongoing developments in Alberta’s healthcare procurement. Read the full CBC report here. Explore other articles on our site for more in-depth analysis of healthcare policy and government accountability.
